How I would treat patients with R/R DLBCL in 2023 and the future

During the Lymphoma Hub Steering Committee meeting, Marek Trněný chaired a discussion on, How I would treat patients with R/R DLBCL in 2023 and the future.

This discussion also featured Gilles Salles, Grzegorz Nowakowski, Martin Dreyling, Judith Trotman, Ulrich Jӓger, and Astrid Pavlovsky. The panel discussed:

• questions and factors considered for subsequent treatment, such as autologous stem cell transplant or CAR T-cell therapy;
• the impact of access to CAR T-cell therapy and when eligible patients can receive treatment after relapse; and
• the importance of time to relapse in deciding treatment.